Knowledge, attitude, and practice among healthcare professionals of adverse drug reactions reporting in a tertiary care center.
Loading...
Date
2015-03
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Background: There has been a rapid increase in the number of drugs entering
the market from last few decades. Preclinical and clinical data are insuffi cient
to conclude the complete safety of drugs. Hence, it is necessary to have a robust
pharmacovigilance system in place to generate safety signals. Under reporting of
adverse drug reactions (ADRs) exists as an inherent weakness of current voluntary
reporting scheme. This study was therefore taken up, to evaluate the knowledge,
attitude, and practice about ADR reporting among doctors in a tertiary care center.
Methods: The present study was a cross-sectional questionnaire-based study, which
included prescribers of a tertiary care teaching hospital. We tried to fi nd out the
possible ways to improve reporting of ADR and factors responsible for defi cient
reporting of ADRs.
Results: After analyzing the data, we observed that 59% of the responders were aware
of the ADRs reporting system. And the most encouraging fi nding was 94% of the
respondents think that this reporting system is necessary. However, the practice was
very poor just 14% among the respondents. 74% and 61% of participants felt creating
awareness among healthcare professionals, and training to healthcare professionals
would lead to improvement in reporting of ADRs respectively. Main factors which
discouraged ADR reporting by healthcare professionals were reporting would lead
to extra work 70.5%, non-availability of forms 64.5%.
Conclusion: The defi ciencies in ADR reporting require attention so as to improve
spontaneous reporting and enhance safety of patients.
Description
Keywords
Pharmacovigilance, Safety signals, Under-reporting
Citation
Dharmadhikari Pranita P, Date Amit P, Patil Kartik S. Knowledge, attitude, and practice among healthcare professionals of adverse drug reactions reporting in a tertiary care center. International Journal of Basic & Clinical Pharmacology. 2015 Mar-Apr; 4(2): 300-305.